60 Degrees Pharmaceuticals announces 2025 annual results

60 Degrees Pharmaceuticals has reported its full-year 2025 financial results, showing a 65% increase in revenue to $1.0 million. The company also reported an improved net loss, indicating progress in its financial performance. Momentum was maintained across clinical, commercial, and partnership activities throughout the year. These results suggest positive development for the company as it continues to advance its strategic objectives in the pharmaceutical sector.